Almanack Investment Partners, Llc. Merck & Co., Inc. Transaction History

Almanack Investment Partners, Llc.

$602 Million
Q4 2024

A detailed history of Almanack Investment Partners, Llc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Almanack Investment Partners, Llc. holds 3,241 shares of MRK stock, worth $295,806. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,241

Previous 3,100 4.55%

Holding current value

$295,806

Previous $352,000 8.52%

% of portfolio

0.05%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$96.31 - $114.76 $13,579 - $16,181	141 Added 4.55%	3,241 $322,000
Q3 2024 Oct 31, 2024	SELL	$111.15 - $128.97 $42,348 - $49,137	-381 Reduced 10.95%	3,100 $352,000
Q2 2024 Aug 09, 2024	BUY	$123.8 - $132.96 $6,437 - $6,913	52 Added 1.52%	3,481 $430,000
Q1 2024 May 01, 2024	BUY	$113.24 - $131.95 $27,064 - $31,536	239 Added 7.49%	3,429 $452,000
Q4 2023 Feb 07, 2024	BUY	$100.18 - $109.02 $13,624 - $14,826	136 Added 4.45%	3,190 $347,000
Q3 2023 Oct 05, 2023	SELL	$102.95 - $114.33 $155,454 - $172,638	-1,510 Reduced 33.09%	3,054 $314,000
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $7,168 - $7,813	-66 Reduced 1.43%	4,564 $526,000
Q1 2023 May 08, 2023	SELL	$102.94 - $114.86 $10,294 - $11,486	-100 Reduced 2.11%	4,630 $492,000
Q4 2022 Feb 08, 2023	SELL	$87.44 - $112.11 $620,474 - $795,532	-7,096 Reduced 60.0%	4,730 $524,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $286,556 - $321,914	3,390 Added 40.18%	11,826 $1.02 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $4,508 - $5,110	54 Added 0.64%	8,436 $775,000
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $60,645 - $67,980	825 Added 10.92%	8,382 $694,000
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $87,747 - $109,915	-1,214 Reduced 13.84%	7,557 $584,000
Q3 2021 Nov 04, 2021	BUY	$71.68 - $78.83 $101,140 - $111,229	1,411 Added 19.17%	8,771 $664,000
Q2 2021 Aug 04, 2021	SELL	$70.31 - $77.77 $78,817 - $87,180	-1,121 Reduced 13.22%	7,360 $577,000
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $39,869 - $46,962	579 Added 7.33%	8,481 $659,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $185,956 - $206,373	2,591 Added 48.79%	7,902 $651,000
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $84,888 - $96,222	1,160 Added 27.95%	5,311 $431,000
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $2,464 - $2,804	-35 Reduced 0.84%	4,151 $324,000
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $265,224 - $367,614	4,186 New	4,186 $324,000
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $290,692 - $328,012	-3,747 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$76.08 - $82.93 $4,716 - $5,141	-62 Reduced 1.63%	3,747 $317,000
Q2 2019 Jul 31, 2019	BUY	$69.84 - $81.59 $266,020 - $310,776	3,809 New	3,809 $0
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $119,120 - $135,864	-1,712 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$65.24 - $75.71 $8,872 - $10,296	-136 Reduced 7.36%	1,712 $132,000
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $106,611 - $125,368	1,848 New	1,848 $139,000

Others Institutions Holding MRK

# of Institutions

3,956

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $231B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.

Account

Almanack Investment Partners, Llc. Merck & Co., Inc. Transaction History